Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients.
Xiaoli MuYixin ZhouQing LiuJiantao WangFeng XuFeng LuoKe WangLu LiPanwen TianYalun LiJiewei LiuYan ZhangZhenhua LiuYan LiPublished in: Cancer medicine (2024)
Thus, weconfirmed that the addition of tRT to the conventional regimen of first-linechemotherapy and immunotherapy yields better survival outcomes without asignificant increase in toxicity.